But_home
But_blogshome
But_forum
Icon_rss_infobarSubscribe to receive updates
on new articles and posts from this blog.
 

Low-dose aspirin for primary prevention

Posted Jun 17, 2009 at 02:03 PM, EDT by Eric Topol

A new meta-analysis questions the use of low-dose aspirin for the prevention of cardiovascular events. Given its current wide use, these findings are important and have far-reaching consequences. What are your thoughts?

See:

Meta-analysis questions use of aspirin in primary prevention

Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.

Algra A and Greving JP. Aspirin in primary prevention: sex and baseline risk matter. Lancet 2009; 373: 1821-1822.

1 comment1 commentaire | Post a comment | Permalink

CommentsCommentaires

Aloha!What recommendations would you recommend? As a non-academic clinical physician, are there objective findings, on physical exam, or lab tests which i might be able to utilize which would allow me to make the most prudent recommendation? Mah... more »
Posted by Madhup Joshi, MD at Thu Jun 25 20:37:15 -0400 2009
Rédigé par Madhup Joshi, MD le 06.17.2009 à 14h03
Blogs
Topol and Teirstein: The Click and Rub Show
The Bob Harrington Show Bob-harrington-show
Private Practice Private-practice
The Fellows' Corner Fellows-corner-radio
Heartfelt: News and views from Dr Melissa Walton-Shirley Melissa-walton-shirley-blog
The Clotblog Clot-blog
Who's talking
Photo
Eric J Topol MD
Director, Scripps Translational Science Institute (STSI)
Dean, Scripps School of Medicine
Chief Academic Officer, Scripps Health
La Jolla, CA
 
General links
The moderator of this blog has compiled the following series of relevant articles: